|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/19 | |
| A61K 47/02 | |||
| A61K 47/26 | |||
| A61K 9/00 | |||
| A61K 39/395 |
| (11) | Number of the document | 2081553 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07839335.2 |
| Date of filing the European patent application | 2007-10-05 | |
| (97) | Date of publication of the European application | 2009-07-29 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/021477 |
| Date | 2007-10-05 |
| (87) | Number | WO 2008/045373 |
| Date | 2008-04-17 |
| (30) | Number | Date | Country code |
| 850362 P | 2006-10-06 | US | |
| 850970 P | 2006-10-10 | US |
| (72) |
MCAULEY, Arnold, US
REHDER, Douglas, US
MATSUMURA, Masazumi, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | STABLE ANTIBODY FORMULATIONS |
| STABLE ANTIBODY FORMULATIONS |